https://pharmadog.xyz/news/650575 pharmadog en 2026-11-07T16:57:13.000Z Biotech Trade Group BIO Sues Over Medicare GLOBE Pricing Pilot https://pharmadog.xyz/news/650215 pharmadog en 2026-11-07T14:50:59.000Z Novo and Novartis see heart drug setbacks as trials show minimal efficacy https://pharmadog.xyz/news/650407 pharmadog en 2026-11-07T14:50:00.000Z STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy https://pharmadog.xyz/news/650408 pharmadog en 2026-11-07T14:35:00.000Z Novo Nordisk’s anti-inflammatory drug ziltivekimab fails to cut heart events, but cardiologists still eye inflammation pathway https://pharmadog.xyz/news/649603 pharmadog en 2026-11-07T11:00:46.000Z Democrats Take House, Raising Questions for Biopharma Policy https://pharmadog.xyz/news/647667 pharmadog en 2026-11-07T00:52:09.000Z Harvard scientist George Church quits AI startup Radical, alleging partner stole his credit https://pharmadog.xyz/news/647287 pharmadog en 2026-11-06T22:05:39.000Z States sue Trump administration to halt Medicaid work-requirement rollout https://pharmadog.xyz/news/647119 pharmadog en 2026-11-06T21:55:21.000Z Former MAHA official Calley Means blames White House for yielding to industry pressure https://pharmadog.xyz/news/647120 pharmadog en 2026-11-06T21:46:55.000Z Newly elected scientists aim to restore health equity programs cut by Trump administration https://pharmadog.xyz/news/646339 pharmadog en 2026-11-06T17:46:16.000Z Democrats’ Midterm Win Promises Medicaid Reversal and ACA Subsidy Restoration for Hospitals https://pharmadog.xyz/news/646340 pharmadog en 2026-11-06T17:02:18.000Z Podcast examines Democrats' midterm win and concerns over a costly, questionable fertility genetic procedure https://pharmadog.xyz/news/646295 pharmadog en 2026-11-06T17:00:22.000Z Immunocore reports early data showing 70% two-year survival with brenetafusp/Kimmtrak combo in uveal melanoma https://pharmadog.xyz/news/646127 pharmadog en 2026-11-06T16:53:33.000Z FDA grants accelerated approval to J&J's Rybrevant for recurrent head and neck cancer https://pharmadog.xyz/news/646359 pharmadog en 2026-11-06T16:51:00.000Z Novartis reports nine cancer cases in patients treated with Zolgensma gene therapy https://pharmadog.xyz/news/646171 pharmadog en 2026-11-06T16:43:49.000Z MetaVia appoints Sarah Browne as chief medical officer https://pharmadog.xyz/news/646151 pharmadog en 2026-11-06T16:43:26.000Z Moderna reports 29% revenue rise as COVID vaccine sales stay steady amid global uptake https://pharmadog.xyz/news/646172 pharmadog en 2026-11-06T16:14:40.000Z New evidence links AAV gene therapies to tumor risk, raising safety concerns https://pharmadog.xyz/news/646128 pharmadog en 2026-11-06T16:08:42.000Z Amgen's Repatha shows reduced heart attack risk while Satellos alters Duchenne trial endpoint https://pharmadog.xyz/news/134233 pharmadog en 2026-11-06T15:46:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/645984 pharmadog en 2026-11-06T15:25:02.000Z Forge Biologics VP sees AI and Ohio talent driving next wave of gene therapy manufacturing https://pharmadog.xyz/news/646003 pharmadog en 2026-11-06T15:14:53.000Z Amgen’s Repatha linked to fewer heart attacks while Novartis reports seven new tumor cases in Zolgensma patients https://pharmadog.xyz/news/645727 pharmadog en 2026-11-06T14:59:42.000Z Study finds ritual cannabis use in 2,800-year-old Siberian tomb https://pharmadog.xyz/news/645728 pharmadog en 2026-11-06T14:41:03.000Z Novartis reports seven tumor cases in children treated with Zolgensma https://pharmadog.xyz/news/645707 pharmadog en 2026-11-06T14:21:05.000Z Agios cuts over 35% of R&D staff as FDA decision on sickle cell drug is delayed https://pharmadog.xyz/news/645708 pharmadog en 2026-11-06T14:19:01.000Z Sarepta CEO Sees Path to Stronger DMD Trials Amid 2025 Elevidys Setbacks https://pharmadog.xyz/news/645683 pharmadog en 2026-11-06T14:10:47.000Z Sarepta halts enrollment in confirmatory Phase 3 trial of Elevidys gene therapy for Duchenne muscular dystrophy https://pharmadog.xyz/news/645747 pharmadog en 2026-11-06T13:13:00.000Z Eli Lilly partners with Hims & Hers to sell Zepbound and Foundayo via telehealth platform https://pharmadog.xyz/news/645539 pharmadog en 2026-11-06T13:04:52.000Z Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November https://pharmadog.xyz/news/645515 pharmadog en 2026-11-06T13:02:48.000Z Moderna posts first profit in two years, driven by Covid-19 vaccine sales, as it refocuses on cancer vaccines https://pharmadog.xyz/news/645371 pharmadog en 2026-11-06T12:35:21.000Z Merck and Moderna report 99% manufacturing success and 42% lower recurrence risk for personalized melanoma vaccine in Phase 3 trial https://pharmadog.xyz/news/645347 pharmadog en 2026-11-06T12:00:44.000Z Novo and Pfizer appoint new CFOs while Alnylam sees departure of its chief commercial officer https://pharmadog.xyz/news/645243 pharmadog en 2026-11-06T12:00:00.000Z Novo Nordisk’s oral Wegovy sales beat forecasts, boosting shares over 5% https://pharmadog.xyz/news/646271 pharmadog en 2026-11-06T10:13:00.000Z Axiom Biosciences pursues Hong Kong IPO and novel stem cell platform amid funding challenges https://pharmadog.xyz/news/646273 pharmadog en 2026-11-06T09:52:00.000Z Moderna pauses norovirus vaccine trial after missing interim analysis https://pharmadog.xyz/news/644889 pharmadog en 2026-11-06T09:30:00.000Z Kratom use rises as health officials warn of addiction risk and push emergency bans https://pharmadog.xyz/news/644888 pharmadog en 2026-11-06T09:30:00.000Z Medical records often miss women's health experiences, limiting AI's potential https://pharmadog.xyz/news/644887 pharmadog en 2026-11-06T09:30:00.000Z Medicare delays controversial remote patient monitoring ban to 2029, opening window for provider pushback https://pharmadog.xyz/news/644890 pharmadog en 2026-11-06T09:30:00.000Z Opinion: STAT+: What it’s like to live with cognitively unimpaired Alzheimer’s disease https://pharmadog.xyz/news/646274 pharmadog en 2026-11-06T04:21:00.000Z Merck ends Sutro partnership on IL-2 agonist MK-1484 amid routine pipeline prioritization https://pharmadog.xyz/news/646275 pharmadog en 2026-11-06T02:36:00.000Z Siemens Healthineers to spin off in‑vitro diagnostics unit as Olyrian Diagnostics, rebranding to Healthineers https://pharmadog.xyz/news/647317 pharmadog en 2026-11-06T00:00:00.000Z Regulators urge risk-based lifecycle approach for AI tools amid election-linked FDA uncertainty https://pharmadog.xyz/news/647318 pharmadog en 2026-11-06T00:00:00.000Z Regulatory experts urge risk-based, lifecycle validation for AI tools in FDA work https://pharmadog.xyz/news/642862 pharmadog en 2026-11-05T22:30:38.000Z FDA grants accelerated approval for Rybrevant Faspro in recurrent/metastatic head and neck cancer https://pharmadog.xyz/news/642655 pharmadog en 2026-11-05T21:36:52.000Z PhRMA spent roughly $59 million on search ads to shape public views on drug pricing https://pharmadog.xyz/news/642675 pharmadog en 2026-11-05T21:06:00.000Z Medicare to slash 340B drug payments and expand site-neutral rules in 2027 https://pharmadog.xyz/news/642443 pharmadog en 2026-11-05T20:52:52.000Z New treatments for preeclampsia move closer to patients https://pharmadog.xyz/news/642487 pharmadog en 2026-11-05T20:49:33.000Z Ballot measures on abortion, marijuana and transgender youth care highlight political divides in 2026 midterms https://pharmadog.xyz/news/642275 pharmadog en 2026-11-05T19:19:22.000Z AAFP chief urges Congress to add oversight to CDC vaccine advisory panel https://pharmadog.xyz/news/642043 pharmadog en 2026-11-05T18:53:34.000Z Novartis reports seven new tumor cases in children treated with Zolgensma gene therapy